Bone marker testing frequency limitation for osteoporosis
This policy governs reimbursement frequency limits for bone marker testing billed to UnitedHealthcare Medicare Advantage on CMS 1500/UB04; it affects providers billing for osteoporosis-related bone marker tests for UnitedHealthcare Medicare Advantage members.
No material clinical or coverage changes in this revision.
Reimbursement Frequency Criteria
Reimbursement frequency criteria
Frequency and applicability rules for reimbursement of bone marker testing billed for osteoporosis:
Codes and Interval Definitions
| No codes listed |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.